GR3022546T3 - Inositol phosphate analogues as calcium-antagonistic substances - Google Patents
Inositol phosphate analogues as calcium-antagonistic substancesInfo
- Publication number
- GR3022546T3 GR3022546T3 GR970400235T GR970400235T GR3022546T3 GR 3022546 T3 GR3022546 T3 GR 3022546T3 GR 970400235 T GR970400235 T GR 970400235T GR 970400235 T GR970400235 T GR 970400235T GR 3022546 T3 GR3022546 T3 GR 3022546T3
- Authority
- GR
- Greece
- Prior art keywords
- calcium
- inositol phosphate
- phosphate analogues
- antagonistic substances
- antagonistic
- Prior art date
Links
- INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical class OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 title 1
- 230000002213 calciumantagonistic effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 239000010452 phosphate Substances 0.000 abstract 2
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4081—Esters with cycloaliphatic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91110546 | 1991-06-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3022546T3 true GR3022546T3 (en) | 1997-05-31 |
Family
ID=8206868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR970400235T GR3022546T3 (en) | 1991-06-26 | 1997-02-12 | Inositol phosphate analogues as calcium-antagonistic substances |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5395828A (el) |
| EP (1) | EP0520372B1 (el) |
| JP (1) | JP3161813B2 (el) |
| KR (1) | KR930000527A (el) |
| AT (1) | ATE145911T1 (el) |
| CA (1) | CA2072303A1 (el) |
| DE (1) | DE69215588T2 (el) |
| DK (1) | DK0520372T3 (el) |
| ES (1) | ES2095985T3 (el) |
| GR (1) | GR3022546T3 (el) |
| HU (2) | HUT64081A (el) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2978995A (en) * | 1994-06-30 | 1996-01-25 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Methods for treating cell proliferative disorders by modulating signal transduction |
| US6939857B2 (en) | 2000-05-12 | 2005-09-06 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
| US6716826B2 (en) | 2000-05-12 | 2004-04-06 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
| US6759390B2 (en) | 2000-05-12 | 2004-07-06 | Manuel Martin-Lomas | Compounds and their uses |
| US6953781B2 (en) | 2000-05-12 | 2005-10-11 | Rodaris Pharmaceuticals Limited | Compounds and their uses |
| ATE358486T1 (de) * | 2000-11-09 | 2007-04-15 | Contrimmune Biotechnology Inc | Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4515722A (en) * | 1982-03-30 | 1985-05-07 | Merck & Co., Inc. | Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents |
| DE3783694T2 (de) * | 1986-03-11 | 1993-05-19 | Mitsui Toatsu Chemicals | Verfahren zur herstellung von myoinositolabkoemmlingen. |
| SE8605063D0 (sv) * | 1986-11-26 | 1986-11-26 | Matti Siren | Derivatives of cyclohexane |
-
1992
- 1992-06-23 DK DK92110563.1T patent/DK0520372T3/da active
- 1992-06-23 AT AT92110563T patent/ATE145911T1/de active
- 1992-06-23 EP EP92110563A patent/EP0520372B1/en not_active Expired - Lifetime
- 1992-06-23 DE DE69215588T patent/DE69215588T2/de not_active Expired - Lifetime
- 1992-06-23 ES ES92110563T patent/ES2095985T3/es not_active Expired - Lifetime
- 1992-06-24 US US07/903,485 patent/US5395828A/en not_active Expired - Lifetime
- 1992-06-24 HU HU9202103A patent/HUT64081A/hu unknown
- 1992-06-25 KR KR1019920011075A patent/KR930000527A/ko active IP Right Grant
- 1992-06-25 JP JP16740192A patent/JP3161813B2/ja not_active Expired - Lifetime
- 1992-06-25 CA CA002072303A patent/CA2072303A1/en not_active Abandoned
-
1995
- 1995-06-28 HU HU95P/P00494P patent/HU211491A9/hu unknown
-
1997
- 1997-02-12 GR GR970400235T patent/GR3022546T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5395828A (en) | 1995-03-07 |
| CA2072303A1 (en) | 1992-12-27 |
| ATE145911T1 (de) | 1996-12-15 |
| JP3161813B2 (ja) | 2001-04-25 |
| EP0520372B1 (en) | 1996-12-04 |
| ES2095985T3 (es) | 1997-03-01 |
| DE69215588D1 (de) | 1997-01-16 |
| HUT64081A (en) | 1993-11-29 |
| JPH05213975A (ja) | 1993-08-24 |
| HU9202103D0 (en) | 1992-10-28 |
| EP0520372A1 (en) | 1992-12-30 |
| DE69215588T2 (de) | 1997-05-15 |
| HU211491A9 (en) | 1995-11-28 |
| DK0520372T3 (da) | 1997-05-12 |
| KR930000527A (ko) | 1993-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW218869B (el) | ||
| IL94915A0 (en) | Substituted quinazolinones and pharmaceutical compositions containing them | |
| GR3035148T3 (en) | Retroviral protease inhibiting compounds. | |
| GR3023130T3 (en) | Phosphotriester-type biologically active compounds. | |
| SG54203A1 (en) | Novel 7- (substituted)-8-(substituted)-9- [(substituted glycyl]-6-demethyl-6-deoxytetracyclines | |
| DK0511541T3 (el) | ||
| EP0444659A3 (en) | A pharmaceutical solution | |
| GR3030718T3 (en) | Novel prostaglandin analogue. | |
| EP0924199A4 (el) | ||
| ZA883444B (el) | ||
| FI935318A (fi) | 15-deoksispergualiinianalogit, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa | |
| EP0328634A4 (en) | Pharmaceutical compositions for the treatment of psoriasis | |
| GR3022546T3 (en) | Inositol phosphate analogues as calcium-antagonistic substances | |
| GB9302046D0 (en) | Antiumoral compound-v | |
| ZA893346B (en) | Anticoagulant peptide alcohols | |
| DE3870954D1 (de) | Zahnaerztliche haftmittelzusammensetzung. | |
| HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
| GR3007465T3 (el) | ||
| EP0430552A3 (en) | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds | |
| ES2067717T3 (es) | Compuestos de acidos propano-fosfinicos p-sustituidos. | |
| ZA899821B (en) | Novel compounds | |
| ZA927307B (en) | Method for treating hypertension | |
| EP0324472A3 (en) | Ketenedithioacetal derivatives and processes for producing the same as well as a composition containing the same | |
| AU6029090A (en) | Improvements in or relating to organic compounds |